This content is machine translated Online training Swiss Oncology in Motion Ovarian Cancer Module Around 600 women are affected by ovarian cancer in Switzerland every year. Due to the non-specific symptoms, the disease is often only diagnosed at an advanced stage and most patients…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion Pancreatic Cancer Module The Pancreatic Cancer module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by Raphaël Delaloye, MD, (Department of Oncology, University Hospital Basel), PD… CME-Test
View Post 5 min This content is machine translated Lung cancer Lung cancer in focus: What’s new? Overall survival of patients with lung cancer has increased by approximately 15% over the past decade. This is primarily due to new therapeutic options, including targeted drugs. However, in order…
View Post 10 min This content is machine translated Chemo in hospice? Systems therapies for metastatic NSCLC in poor general health. Non-small cell lung cancer (NSCLC) is the cancer with the highest mortality worldwide, with two-thirds of cases detected only at locally advanced or metastatic stages. Unfortunately, recommendations for patients with… CME-Test
View Post 4 min This content is machine translated Colorectal cancer screening in ulcerative colitis and Crohn's disease Virtual chromoendoscopy without additional benefit Patients with ulcerative colitis and Crohn’s disease who undergo colonoscopies for surveillance significantly reduce the risk of dying from colorectal cancer. White light videoendoscopy (WLE) is still considered the standard,…
View Post 8 min This content is machine translated Vulvar and vaginal carcinoma Update: precancerous lesions, classification and therapy While vaginal cancer is a rarity, cases of vulvar cancer have increased significantly worldwide over the past 20 years. It is the female carcinoma whose incidence is increasing most rapidly.…
View Post 2 min This content is machine translated Breast Cancer Regulatory extension for anti-PD-1 therapy with pembrolizumab Swissmedic has granted a further marketing authorization for anti-PD-1 therapy with pembrolizumab. This can now be approved in combination with chemotherapy in Switzerland for the treatment of patients with locally…
View Post 2 min This content is machine translated Neoadjuvant treatment with T-VEC Preoperative immunotherapy improves prognosis in metastatic melanoma In a study involving dermatologists from the University Hospital Zurich, preoperative immunotherapy was shown to increase the likelihood of survival and a longer recurrence-free interval in melanoma patients. For patients,…
View Post 9 min This content is machine translated Castleman's disease When is lymph node swelling serious? Periodic, very painful and extensive lymph node swelling may also indicate a rare Castleman’s disease. The rare disease is divided into unicentric Castleman’s disease (UCD) and multicentric forms. The multicentric… CME-Test
View Post 4 min This content is machine translated Non-small cell lung cancer The first targeted therapy for KRAS G12C mutation [1]. After decades of effort, it is now possible for the first time to provide patients with KRAS G12C-mutated non-small cell lung cancer with an effective targeted therapy [1,2]. In the…
View Post 9 min This content is machine translated Hepatocellular carcinoma Systemic treatment of HCC – combination therapies on the rise Hepatocellular carcinoma (HCC) is the most common primary liver cell tumor and presents a challenge in systemic treatment with its intrinsic resistance to classical chemotherapeutic agents. The responsible clinician must… CME-Test
